AU2015280296B2 - Binding partners specific for vitamin D epimers in vitamin D assays - Google Patents

Binding partners specific for vitamin D epimers in vitamin D assays Download PDF

Info

Publication number
AU2015280296B2
AU2015280296B2 AU2015280296A AU2015280296A AU2015280296B2 AU 2015280296 B2 AU2015280296 B2 AU 2015280296B2 AU 2015280296 A AU2015280296 A AU 2015280296A AU 2015280296 A AU2015280296 A AU 2015280296A AU 2015280296 B2 AU2015280296 B2 AU 2015280296B2
Authority
AU
Australia
Prior art keywords
vitamin
antibody
analyte
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015280296A
Other languages
English (en)
Other versions
AU2015280296A1 (en
Inventor
Jie Li
Manoj Sharma
Zhu Teng
Tie Quan Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Publication of AU2015280296A1 publication Critical patent/AU2015280296A1/en
Application granted granted Critical
Publication of AU2015280296B2 publication Critical patent/AU2015280296B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76—Chemiluminescence; Bioluminescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AU2015280296A 2014-06-27 2015-06-22 Binding partners specific for vitamin D epimers in vitamin D assays Active AU2015280296B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462018020P 2014-06-27 2014-06-27
US62/018,020 2014-06-27
PCT/US2015/036912 WO2015200186A1 (en) 2014-06-27 2015-06-22 Binding partners specific for vitamin d epimers in vitamin d assays

Publications (2)

Publication Number Publication Date
AU2015280296A1 AU2015280296A1 (en) 2016-12-15
AU2015280296B2 true AU2015280296B2 (en) 2019-07-18

Family

ID=54938701

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015280296A Active AU2015280296B2 (en) 2014-06-27 2015-06-22 Binding partners specific for vitamin D epimers in vitamin D assays

Country Status (8)

Country Link
US (1) US9746484B2 (ja)
EP (1) EP3161005B1 (ja)
JP (1) JP6749253B2 (ja)
KR (2) KR20170016009A (ja)
CN (1) CN106661114B (ja)
AU (1) AU2015280296B2 (ja)
ES (1) ES2853525T3 (ja)
WO (1) WO2015200186A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016030507B1 (pt) * 2014-06-27 2023-03-28 Siemens Healthcare Diagnostics Inc Compostos relacionados à vitamina d, e composição farmacêutica
WO2018023066A1 (en) 2016-07-29 2018-02-01 Diazyme Laboratories, Inc. Methods and compositions for assaying vitamin d
JPWO2021100841A1 (ja) * 2019-11-22 2021-05-27
CN116500281B (zh) * 2023-06-26 2023-11-07 天津赛飞乐生物技术有限公司 1,25-二羟基维生素d的检测材料及制备方法、1,25-二羟基维生素d的检测方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014134139A1 (en) * 2013-02-28 2014-09-04 Siemens Healthcare Diagnostics Inc. Methods and reagents for determining isomeric analytes

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4233402A (en) 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
US4661408A (en) 1986-03-18 1987-04-28 E.I. Du Pont De Nemours And Company Coated chromium dioxide particles
WO1989000446A1 (en) 1987-07-16 1989-01-26 E.I. Du Pont De Nemours And Company Affinity separating using immobilized flocculating reagents
US5089390A (en) 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US5158871A (en) 1988-02-12 1992-10-27 University Of Connecticut Method of using magnetic particles for isolating, collecting and assaying diagnostic ligates
US5147529A (en) 1988-08-10 1992-09-15 E. I. Du Pont De Nemours And Company Method for automatically processing magnetic solid phase reagents
US5151348A (en) 1988-12-23 1992-09-29 E. I. Du Pont De Nemours And Company Enzyme-linked immunoassay for measurement of cyclosporin a levels in whole blood samples
US5101015A (en) 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
US5128103A (en) 1990-12-14 1992-07-07 E. I. Du Pont De Nemours And Company Apparatus for automatically processing magnetic solid phase reagents
US5578498A (en) 1991-05-22 1996-11-26 Behringwerke Ag Metal chelate containing compositions for use in chemiluminescent assays
US5340716A (en) 1991-06-20 1994-08-23 Snytex (U.S.A.) Inc. Assay method utilizing photoactivated chemiluminescent label
US6251581B1 (en) 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
JPH06509646A (ja) 1991-07-26 1994-10-27 デイド・ケミストリイ・システムズ・インコーポレーテツド 懸濁された固体支持体の存在下でのシグナル検出アッセイ
DK0653066T3 (da) 1992-07-31 1998-09-23 Dade Behring Marburg Gmbh Fotoaktiverbare kemiluminescerende matricer
JPH09143154A (ja) 1995-11-20 1997-06-03 Kureha Chem Ind Co Ltd ビタミンｄ３ 誘導体の製造方法
WO1997024127A1 (en) 1995-12-29 1997-07-10 A And D Assay, Incorporated Labeled vitamin d compounds and the use thereof
US5929049A (en) 1997-08-08 1999-07-27 Dade Behring Marburg Gmbh Polysaccharide conjugates of biomolecules
US6153442A (en) 1998-05-20 2000-11-28 Dade Behring Inc. Reagents and methods for specific binding assays
US6787660B1 (en) 1998-06-25 2004-09-07 Immundiagnostik Ag Functional vitamin D derivatives and a method for determining 25-hydroxy-vitamin D and 1α, dihydroxy-vitamin D
WO2000009487A1 (en) 1998-08-11 2000-02-24 Bayer Corporation Near infrared chemiluminescent acridinium compounds and uses thereof
US6673560B1 (en) 1998-11-25 2004-01-06 Bayer Corporation Measurement of hydride using chemiluminescent acridinium compounds and applications thereof
US6783948B1 (en) 1999-07-30 2004-08-31 Bayer Corporation Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes
US6703248B1 (en) 1999-12-15 2004-03-09 Dade Behring Marburg Gmbh Particles for diagnostic and therapeutic use
US7179660B1 (en) 2000-03-06 2007-02-20 Dade Behring Marburg Gmbh Carriers coated with polysaccharides, their preparation and use
US7319041B2 (en) 2002-09-27 2008-01-15 Siemens Medical Solutions Diagnostic Applications of acridinium compounds and derivatives in homogeneous assays
US7186518B2 (en) 2003-11-21 2007-03-06 Dade Behring Inc. Method and composition useful for determining FK 506
US20050118727A1 (en) 2003-12-01 2005-06-02 Carsten Schelp Conjugates and their use in detection methods
WO2005067673A2 (en) 2004-01-06 2005-07-28 The University Of Tennessee Research Foundation Enzymatic method to produce 7-dehydropregnenolone, vitamin d3-like compounds and derivatives thereof
US7172906B2 (en) 2004-11-16 2007-02-06 Dade Behring Inc. Reduction of non-specific binding in assays
WO2006096555A1 (en) 2005-03-04 2006-09-14 Women And Infants Hospital Of Ri, Inc. Compositions and methods for cancer treatment
US8785603B2 (en) * 2011-05-20 2014-07-22 Siemens Healthcare Diagnostics Inc. Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof
CA3062003C (en) 2012-05-17 2022-01-11 Extend Biosciences, Inc. Vitamin d as a targeting group for therapeutic peptides
US9719970B2 (en) * 2012-11-30 2017-08-01 Waters Technologies Corporation Methods and apparatus for the analysis of vitamin D metabolites
US20140308751A1 (en) 2013-04-12 2014-10-16 Siemens Healthcare Diagnostics Inc. Assays for Analyte Homologs
US9804176B2 (en) * 2014-06-27 2017-10-31 Siemens Healthcare Diagnostics Inc. Assays for vitamin D epimers

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014134139A1 (en) * 2013-02-28 2014-09-04 Siemens Healthcare Diagnostics Inc. Methods and reagents for determining isomeric analytes

Also Published As

Publication number Publication date
ES2853525T3 (es) 2021-09-16
EP3161005A1 (en) 2017-05-03
KR20170016009A (ko) 2017-02-10
CN106661114B (zh) 2019-01-29
EP3161005B1 (en) 2020-11-25
US20170168076A1 (en) 2017-06-15
JP6749253B2 (ja) 2020-09-02
CN106661114A (zh) 2017-05-10
BR112016030237A2 (pt) 2017-08-22
KR20180021934A (ko) 2018-03-05
EP3161005A4 (en) 2017-12-06
JP2017519219A (ja) 2017-07-13
BR112016030237A8 (pt) 2021-07-13
US9746484B2 (en) 2017-08-29
AU2015280296A1 (en) 2016-12-15
WO2015200186A1 (en) 2015-12-30

Similar Documents

Publication Publication Date Title
EP3161006B1 (en) Assays for vitamin d epimers
US10399938B2 (en) Compositions relating to vitamin D
AU2015280296B2 (en) Binding partners specific for vitamin D epimers in vitamin D assays
AU2015280292B2 (en) Binding partners specific for vitamin D epimers
BR112016030512B1 (pt) Métodos para determinação de uma quantidade de analito de vitamina d epimérico em uma amostra suspeita de conter o mesmo
BR112016030237B1 (pt) Método para determinação de uma quantidade de analito de vitamina d em uma amostra suspeita de conter o analito de 25oh vitamina d
BR122024007436A2 (pt) Parceiros de ligação específicos para epímeros de vitamina d

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)